Multimerization of Adenovirus Serotype 3 Fiber Knob Domains Is Required for Efficient Binding of Virus to Desmoglein 2 and Subsequent Opening of Epithelial Junctions
Open Access
- 1 July 2011
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 85 (13) , 6390-6402
Abstract
Recently, we identified desmoglein 2 (DSG2) as the main receptor for a group of species B adenoviruses (Ads), including Ad3, a serotype that is widely distributed in the human population (H. Wang et al., Nat. Med. 17: 96–104, 2011). In this study, we have attempted to delineate structural details of the Ad3 interaction with DSG2. For CAR- and CD46-interacting Ad serotypes, attachment to cells can be completely blocked by an excess of recombinant fiber knob protein, while soluble Ad3 fiber knob only inefficiently blocks Ad3 infection. We found that the DSG2-interacting domain(s) within Ad3 is formed by several fiber knob domains that have to be in the spatial constellation that is present in viral particles. Based on this finding, we generated a small recombinant, self-dimerizing protein containing the Ad3 fiber knob (Ad3-K/S/Kn). Ad3-K/S/Kn bound to DSG2 with high affinity and blocked Ad3 infection. We demonstrated by confocal immunofluorescence and transmission electron microscopy analyses that Ad3-K/S/Kn, through its binding to DSG2, triggered the transient opening of intercellular junctions in epithelial cells. The pretreatment of epithelial cells with Ad3-K/S/Kn resulted in increased access to receptors that are localized in or masked by epithelial junctions, e.g., CAR or Her2/ neu . Ad3-K/S/Kn treatment released CAR from tight junctions and thus increased the transduction of epithelial cells by a serotype Ad5-based vector. Furthermore, the pretreatment of Her2/ neu -positive breast cancer cells with Ad3-K/S/Kn increased the killing of cancer cells by the Her2/ neu -targeting monoclonal antibody trastuzumab (Herceptin). This study widens our understanding of how Ads achieve high avidity to their receptors and the infection of epithelial tissue. The small recombinant protein Ad3-K/S/Kn has practical implications for the therapy of epithelial cancer and gene/drug delivery to normal epithelial tissues.Keywords
This publication has 35 references indexed in Scilit:
- Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14Nature Medicine, 2010
- Treatment of Cancer Patients With a Serotype 5/3 Chimeric Oncolytic Adenovirus Expressing GMCSFMolecular Therapy, 2010
- Macropinocytotic Uptake and Infection of Human Epithelial Cells with Species B2 Adenovirus Type 35Journal of Virology, 2010
- Generation and Characterization of Monoclonal Antibodies Against the Proregion of Human Desmoglein-2Hybridoma, 2008
- Mechanisms of Disease: epithelial–mesenchymal transition—does cellular plasticity fuel neoplastic progression?Nature Clinical Practice Oncology, 2008
- Identification of CD46 Binding Sites within the Adenovirus Serotype 35 Fiber KnobJournal of Virology, 2007
- Coxsackievirus Entry across Epithelial Tight Junctions Requires Occludin and the Small GTPases Rab34 and Rab5Cell Host & Microbe, 2007
- A New Group B Adenovirus Receptor Is Expressed at High Levels on Human Stem and Tumor CellsJournal of Virology, 2006
- Development and characterization of a recombinant madin-darby canine kidney cell line that expresses rat multidrug resistance-associated protein 1 (rMRP1)AAPS PharmSci, 2004
- Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions.Proceedings of the National Academy of Sciences, 1991